Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury*-Reference-Cited by-同舟云学术

Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury*

Published:2010-03 Issue:3 Volume:38 Page:903-909
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Mersmann Jan,Berkels Reinhard,Zacharowski Paula,Tran Nguyen,Koch Alexander,Iekushi Kazuma,Dimmeler Stefanie,Granja Tiago F.,Boehm Olaf,Claycomb William C.,Zacharowski Kai

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference45 articles.

1. Toll-like receptors and innate immunity

2. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages

3. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart

4. Toll-Like Receptors 2-Deficient Mice Are Protected Against Postischemic Coronary Endothelial Dysfunction

5. Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient Mice

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pushing the envelope: Immune mechanism and application landscape of macrophage-activating lipopeptide-2;Frontiers in Immunology;2023-01-24

2. Resveratrol regulates paracrine function of cardiac microvascular endothelial cells under hypoxia/reoxygenation condition;PHARMAZIE;2022

3. Potential therapeutic strategies for myocardial infarction: the role of Toll-like receptors;Immunologic Research;2022-05-24

4. Molecular Mechanisms Underlying Intestinal Ischemia/Reperfusion Injury: Bioinformatics Analysis and In Vivo Validation;Medical Science Monitor;2020-12-08

5. Poly(I:C) preconditioning protects the heart against myocardial ischemia/reperfusion injury through TLR3/PI3K/Akt-dependent pathway;Signal Transduction and Targeted Therapy;2020-11-06